Provided by Tiger Trade Technology Pte. Ltd.

Labcorp Holdings Inc

336.34
+3.531.06%
Post-market: 336.340.00000.00%19:30 EDT
Volume:792.68K
Turnover:266.09M
Market Cap:27.21B
PE:27.85
High:336.90
Open:332.68
Low:330.90
Close:332.81
52wk High:338.19
52wk Low:244.52
Shares:80.90M
Float Shares:80.50M
Volume Ratio:1.29
T/O Rate:0.98%
Dividend:2.88
Dividend Rate:0.86%
EPS(TTM):12.08
EPS(LYR):10.46
ROE:11.73%
ROA:5.53%
PB:3.16
PE(LYR):32.15

Loading ...

Labcorp Holdings is Maintained at Neutral by Piper Sandler

Dow Jones
·
Aug 04

Piper Sandler Adjusts Price Target on Labcorp Holdings to $309 From $300, Maintains Neutral Rating

MT Newswires Live
·
Aug 04

Labcorp Launches FDA-Approved Pten Companion Diagnostic for Prostate Cancer

THOMSON REUTERS
·
Aug 04

Labcorp : JP Morgan Raises Target Price to $360 from $330

THOMSON REUTERS
·
Aug 03

UBS Remains a Buy on Labcorp Holdings (LH)

TIPRANKS
·
Jul 31

Labcorp Holdings is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 31

Labcorp Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 31

Fulgent Genetics Q2 Revenue Rises 20% Sequentially, Sees Billing System Transition Delay

Reuters
·
Jul 31

CareDx Q2 Revenue Beats Estimates; Outlook Lifted

Reuters
·
Jul 31

Barclays Raises Labcorp Price Target to $320 From $290, Maintains Equalweight Rating

MT Newswires Live
·
Jul 31

U.S. Stocks on the MOVE-Mastercard, Starbucks, Meta

Reuters
·
Jul 30

Labcorp Releases Transcript of Q2 2026 Earnings Call Webcast Prepared Remarks

Reuters
·
Jul 30

Labcorp Exec Says Specialty Testing Business Continues to Grow Faster than Routine Testing Business, Expects Trend to Continue - Conf Call

THOMSON REUTERS
·
Jul 30

Labcorp Exec Says Oncology Patients Tend to Receive Significantly More Tests over Time than Typical Patients, Driving Higher Tests Per Accession - Conf Call

THOMSON REUTERS
·
Jul 30

Labcorp Exec Says Assumption for About 30 Basis Points Impact to 2026 Diagnostics Volume from Aca-Related Changes Remains Appropriate - Conf Call

THOMSON REUTERS
·
Jul 30

Stock Track | Labcorp Holdings Plunges 5.43% in Pre-market as Diagnostics Revenue Miss Weighs on Strong Q2 Results

Stock Track
·
Jul 30

Labcorp Raises Annual Profit Forecast on Strong Testing Demand

Reuters
·
Jul 30

Labcorp Lifts Outlook as 2Q Profit, Revenue Rise

Dow Jones
·
Jul 30

Labcorp reports Q2 adjusted EPS $4.99, consensus $4.77

TIPRANKS
·
Jul 30

Labcorp FY26 Q2 Diluted EPS Rises 28.5% to $3.64; Revenue Increases 5.8% to $3.73 Billion

Reuters
·
Jul 30